Molecular characterization of late stomal recurrence following total laryngectomy

Oncology Reports

Volumn 25, Issue 3, 2011, Pages 669-676

  Stephen, Josena K ^a   Symal, Mausumi ^a   Chen, Kang Mei ^a   Ghanem, Tamer ^a   Deeb, Robert ^a   Shah, Veena ^a   Havard, Shaleta ^a   Worsham, Maria J ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

DNA methylation; HPV status; Recurrences; Second primary

Indexed keywords

5 METHYLCYTOSINE; APC; BRCA1 ASSOCIATED RING DOMAIN PROTEIN 1; BRCA1 PROTEIN; PROTEIN MLH1;

ADULT; AGED; ARTICLE; BIOPSY; CANCER RECURRENCE; CARCINOGENESIS; CASE REPORT; DNA METHYLATION; GENE LOCUS; GENETIC HETEROGENEITY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; LARYNGECTOMY; LARYNX CARCINOMA; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SECOND CANCER; SQUAMOUS CELL CARCINOMA; STOMA; TUMOR SUPPRESSOR GENE; VIRUS TYPING; WART VIRUS;

AGED; CARCINOMA, SQUAMOUS CELL; DNA METHYLATION; EPIGENOMICS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMAN PAPILLOMAVIRUS 11; HUMAN PAPILLOMAVIRUS 16; HUMANS; LARYNGEAL NEOPLASMS; LARYNGECTOMY; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, SECOND PRIMARY; PAPILLOMAVIRUS INFECTIONS; SURGICAL STOMAS;

EID: 79551581389     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1136     Document Type: Article

References (61)

1. Clayman GL, Lippman SM, Laramore GF, et al: Neoplasms of the head and neck. B.C. Becker Inc., section 27, New York, 2000.
2. Horner MJ, Ries LAG, Krapcho M, Neyman N, Aminou R, Howlader N, Altekruse SF, Feuer EJ, Huang L, Mariotto A, Miller BA, Lewis DR, Eisner MP, Stinchcomb DG and Edwards BK (eds): SEER Cancer Statistics Review, 1975-2006. National Cancer Institute, Bethesda, MD, 2009.
3. Wilson J: Effective Head and Neck Cancer Management. 3rd edition. British Association of Otorhinolaryngologists Head and Neck Surgeons, London, 2000.
4. Parkin DM, Bray F, Ferlay J and Pisani P: Estimating the world cancer burden: Globocan 2000. Int J Cancer 94: 153-156, 2001.
5. Imauchi Y, Ito K, Takasago E, Nibu K, Sugasawa M and Ichimura K: Stomal recurrence after total laryngectomy for squamous cell carcinoma of the larynx. Otolaryngol Head Neck Surg 126: 63-66, 2002.
6. Keim WF, Shapiro MJ and Rosin HD: Study of post-laryngectomy stomal recurrence. Arch Otolaryngol 81: 183-186, 1965.
7. Zbaren P, Greiner R and Kengelbacher M: Stoma recurrence after laryngectomy: an analysis of risk factors. Otolaryngol Head Neck Surg 114: 569-575, 1996.
8. Esteban F, Moreno JA, Delgado-Rodriguez M and Mochon A: Risk factors involved in stomal recurrence following laryngectomy. J Laryngol Otol 107: 527-531, 1993.
9. Rubin J, Johnson JT and Myers EN: Stomal recurrence after laryngectomy: interrelated risk factor study. Otolaryngol Head Neck Surg 103: 805-812, 1990.
10. Thomas R: Late recurrence of laryngeal cancer. J Laryngol Otol 78: 1123-1124, 1964.
11. Modlin B and Ogura JH: Post-laryngectomy tracheal stomal recurrences. Laryngoscope 79: 239-250, 1969.
12. Warren S and Gates O: Multiple primary malignant tumors: a survey of the literature and a statistical study. Am J Cancer 16: 1358-1414, 1932.
13. Yotakis J, Davris S, Kontozoglou T and Adamopoulos G: Evaluation of risk factors for stomal recurrence after total laryngectomy. Clin Otolaryngol Allied Sci 21: 135-138, 1996.
14. Santoro R, Franchi A, Tempesti C, Sardi I and Polli G: Stomal recurrence following total laryngectomy: clinical and molecular analysis of a series. Ann Otol Rhinol Laryngol 112: 594-599, 2003.
15. Costello JF and Plass C: Methylation matters. J Med Genet 38: 285-303, 2001.
16. Li E, Beard C and Jaenisch R: Role for DNA methylation in genomic imprinting. Nature 366: 362-365, 1993.
17. Pfeifer GP, Tanguay RL, Steigerwald SD and Riggs AD: In vivo footprint and methylation analysis by PCR-aided genomic sequencing: comparison of active and inactive X chromosomal DNA at the CpG island and promoter of human PGK-1. Genes Dev 4: 1277-1287, 1990.
18. Costello JF, Fruhwald MC, Smiraglia DJ, et al: Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat Genet 24: 132-138, 2000.
19. Worsham MJ, Pals G, Schouten JP, et al: Delineating genetic pathways of disease progression in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 129: 702-708, 2003.
20. Worsham MJ, Chen KM, Tiwari N, et al: Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 132: 409-415, 2006.
21. Sanchez-Cespedes M, Okami K, Cairns P and Sidransky D: Molecular analysis of the candidate tumor suppressor gene ING1 in human head and neck tumors with 13q deletions. Genes Chromosomes Cancer 27: 319-322, 2000.
22. Maruya S, Issa JP, Weber RS, et al: Differential methylation status of tumor-associated genes in head and neck squamous carcinoma: incidence and potential implications. Clin Cancer Res 10: 3825-3830, 2004.
23. Worsham MJ, Chen KM, Meduri V, et al: Epigenetic events of disease progression in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 132: 668-677, 2006.
24. Stephen JK, Vaught LE, Chen KM, et al: An epigenetically derived monoclonal origin for recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg 133: 684-692, 2007.
25. Stephen JK, Vaught LE, Chen KM, et al: Epigenetic events underlie the pathogenesis of sinonasal papillomas. Mod Pathol 20: 1019-1027, 2007.
26. Gillison ML and Lowy DR: A causal role for human papillomavirus in head and neck cancer. Lancet 363: 1488-1489, 2004.
27. Gillison ML, Koch WM, Capone RB, et al: Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92: 709-720, 2000.
28. Ang KK, Harris J, Wheeler R, et al: Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363: 24-35, 2010.
29. D'Souza G, Kreimer AR, Viscidi R, et al: Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 356: 1944-1956, 2007.
30. Chen AA, Marsit CJ, Christensen BC, et al: Genetic variation in the vitamin C transporter, SLC23A2, modifies the risk of HPV16-associated head and neck cancer. Carcinogenesis 30: 977-981, 2009.
31. Kreimer AR, Clifford GM, Boyle P and Franceschi S: Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 14: 467-475, 2005.
32. Nygren AO, Ameziane N, Duarte HM, et al: Methylation-specific MLPA (MS-MLPA): simultaneous detection of CpG methylation and copy number changes of up to 40 sequences. Nucleic Acids Res 33: e128, 2005.
33. Chen K, Sawhney R, Khan M, et al: Methylation of multiple genes as diagnostic and therapeutic markers in primary head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 133: 1131-1138, 2007.
34. Stephen JK, Vaught LE, Chen KM, Shah V, Schweitzer VG, Gardner G, Benninger MS and Worsham MJ: Consistent aberrant DNA methylation patterns in laryngeal papillomas. Int J Head Neck Surg 1: 69-77, 2010.
35. Bedi GC, Westra WH, Gabrielson E, Koch W and Sidransky D: Multiple head and neck tumors: evidence for a common clonal origin. Cancer Res 56: 2484-2487, 1996.
36. Heppner GH and Miller BE: Therapeutic implications of tumor heterogeneity. Semin Oncol 16: 91-105, 1989.
37. Slaughter DP, Southwick HW and Smejkal W: Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 6: 963-968, 1953.
38. Koch WM, Boyle JO, Mao L, Hakim J, Hruban RH and Sidransky D: p53 gene mutations as markers of tumor spread in synchronous oral cancers. Arch Otolaryngol Head Neck Surg 120: 943-947, 1994.
39. Worsham MJ, Wolman SR, Carey TE, Zarbo RJ, Benninger MS and van Dyke DL: Common clonal origin of synchronous primary head and neck squamous cell carcinomas: analysis by tumor karyotypes and fluorescence in situ hybridization. Hum Pathol 26: 251-261, 1995.
40. Stephen JK, Vaught LE, Chen KM, et al: Epigenetic events underlie the pathogenesis of sinonasal papillomas. Mod Pathol 20: 1019-1027, 2007.
41. Fliss MS, Usadel H, Caballero OL, et al: Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science 287: 2017-2019, 2000.
42. Uesugi H, Uzawa K, Kawasaki K, et al: Status of reduced expression and hypermethylation of the APC tumor suppressor gene in human oral squamous cell carcinoma. Int J Mol Med 15: 597-602, 2005.
43. Stephen JK, Chen K, Shah V, et al: DNA hypermethylation markers of poor outcome in laryngeal cancer. Clin Epigenetics, June 24, 2010 (Epub ahead of print).
44. Liu B, Nicolaides NC, Markowitz S, et al: Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nat Genet 9: 48-55, 1995.
45. Huang KT, Dobrovic A, Yan M, et al: DNA methylation profiling of phyllodes and fibroadenoma tumours of the breast. Breast Cancer Res Treat 124: 555-565, 2010.
46. Seeber LM, Zweemer RP, Marchionni L, et al: Methylation profiles of endometrioid and serous endometrial cancers. Endocr Relat Cancer 17: 663-673, 2010.
47. Griffiths EA, Gore SD, Hooker CM, et al: Epigenetic differences in cytogenetically normal versus abnormal acute myeloid leukemia. Epigenetics 5: Oct 3, 2010 (Epub ahead of print).
48. Sasiadek MM, Stembalska-Kozlowska A, Smigiel R, Ramsey D, Kayademir T and Blin N: Impairment of MLH1 and CDKN2A in oncogenesis of laryngeal cancer. Br J Cancer 90: 1594-1599, 2004.
49. Munoz N, Bosch FX, De Sanjose S, et al: Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348: 518-527, 2003. (Pubitemid 36159887)
50. Herrero R, Hildesheim A, Bratti C, et al: Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst 92: 464-474, 2000.
51. Campisi G and Giovannelli L: Controversies surrounding human papilloma virus infection, head & neck vs oral cancer, implications for prophylaxis and treatment. Head Neck Oncol 1: 8, 2009.
52. Syrjanen K, Syrjanen S and Pyrhonen S: Human papilloma virus (HPV) antigens in lesions of laryngeal squamous cell carcinomas. ORL J Otorhinolaryngol Relat Spec 44: 323-334, 1982. (Pubitemid 12029401)
53. Nichols AC, Faquin WC, Westra WH, et al: HPV-16 infection predicts treatment outcome in oropharyngeal squamous cell carcinoma. Otolaryngol Head Neck Surg 140: 228-234, 2009.
54. Chen R, Aaltonen LM and Vaheri A: Human papillomavirus type 16 in head and neck carcinogenesis. Rev Med Virol 15: 351-363, 2005.
55. Gillison ML, Chaturvedi AK and Lowy DR: HPV prophylactic vaccines and the potential prevention of non-cervical cancers in both men and women. Cancer 113: 3036-3046, 2008.
56. Mounts P, Shah KV and Kashima H: Viral etiology of juvenile-and adult-onset squamous papilloma of the larynx. Proc Natl Acad Sci USA 79: 5425-5429, 1982.
57. Gabbott M, Cossart YE, Kan A, Konopka M, Chan R and Rose BR: Human papillomavirus and host variables as predictors of clinical course in patients with juvenile-onset recurrent respiratory papillomatosis. J Clin Microbiol 35: 3098-3103, 1997.
58. Gissmann L, Wolnik L, Ikenberg H, Koldovsky U, Schnurch HG and zur Hausen H: Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers. Proc Natl Acad Sci USA 80: 560-563, 1983.
59. Hartley C, Hamilton J, Birzgalis AR and Farrington WT: Recurrent respiratory papillomatosis - the Manchester experience, 1974-1992. J Laryngol Otol 108: 226-229, 1994.
60. Lie ES, Karlsen F and Holm R: Presence of human papillomavirus in squamous cell laryngeal carcinomas. A study of thirty-nine cases using polymerase chain reaction and in situ hybridization. Acta Otolaryngol 116: 900-905, 1996.
61. Lele SM, Pou AM, Ventura K, Gatalica Z and Payne D: Molecular events in the progression of recurrent respiratory papillomatosis to carcinoma. Arch Pathol Lab Med 126: 1184-1188, 2002.